These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of verapamil in infants with paroxysmal supraventricular tachycardia.
    Author: Soler-Soler J, Sagristá-Sauleda J, Cabrera A, Sauleda-Parés J, Iglesias-Berengué J, Permanyer-Miralda G, Roca-Llop J.
    Journal: Circulation; 1979 May; 59(5):876-9. PubMed ID: 428098.
    Abstract:
    Twenty-nine consecutive spontaneous attacks of paroxysmal supraventricular tachycardia (PSVT) in 14 infants (mean age 4.4 months) were treated with verapamil. No infant had associated heart disease. Verapamil 1-2 mg i.v was administered over 30 seconds. The dosage varied according to the weight of the infant. Within 60 seconds sinus rhythm was obtained in 28 instances (96.5%). No significant complications were observed. The high effectiveness, rapid action and lack of undesirable side effects observed in this series suggest that verapamil is the drug of choice in the treatment of PSVT in infants without underlying heart disease.
    [Abstract] [Full Text] [Related] [New Search]